Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MCARH109 |
Synonyms | |
Therapy Description |
MCARH109 are autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting GPRC5D and CD137 (4-1BB), which may selective recognize GPRC5D expressing tumor cells and activate anti-tumor immune response (PMID: 36170501). |